| Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus JS McLellan, M Chen, MG Joyce, M Sastry, GBE Stewart-Jones, Y Yang, ... science 342 (6158), 592-598, 2013 | 1055 | 2013 |
| Rapid development of a DNA vaccine for Zika virus KA Dowd, SY Ko, KM Morabito, ES Yang, RS Pelc, CR DeMaso, ... Science 354 (6309), 237-240, 2016 | 430 | 2016 |
| Enhanced neonatal Fc receptor function improves protection against primate SHIV infection SY Ko, A Pegu, RS Rudicell, Z Yang, MG Joyce, X Chen, K Wang, S Bao, ... Nature 514 (7524), 642-645, 2014 | 388 | 2014 |
| Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo RS Rudicell, YD Kwon, SY Ko, A Pegu, MK Louder, IS Georgiev, X Wu, ... Journal of virology 88 (21), 12669-12682, 2014 | 318 | 2014 |
| Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor A Pegu, Z Yang, JC Boyington, L Wu, SY Ko, SD Schmidt, K McKee, ... Science translational medicine 6 (243), 243ra88-243ra88, 2014 | 258 | 2014 |
| Sublingual vaccination with influenza virus protects mice against lethal viral infection JH Song, HH Nguyen, N Cuburu, T Horimoto, SY Ko, SH Park, ... Proceedings of the National Academy of Sciences 105 (5), 1644-1649, 2008 | 238 | 2008 |
| Synthesis and evaluation of 1, 2, 3-triazole containing analogues of the immunostimulant α-GalCer T Lee, M Cho, SY Ko, HJ Youn, DJ Baek, WJ Cho, CY Kang, S Kim Journal of medicinal chemistry 50 (3), 585-589, 2007 | 237 | 2007 |
| A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model HJ Ko, YJ Kim, YS Kim, WS Chang, SY Ko, SY Chang, S Sakaguchi, ... Cancer research 67 (15), 7477-7486, 2007 | 232 | 2007 |
| α-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor SY Ko, HJ Ko, WS Chang, SH Park, MN Kweon, CY Kang The Journal of Immunology 175 (5), 3309-3317, 2005 | 221 | 2005 |
| Broadly neutralizing human immunodeficiency virus type 1 antibody gene transfer protects nonhuman primates from mucosal simian-human immunodeficiency virus infection KO Saunders, L Wang, MG Joyce, ZY Yang, AB Balazs, C Cheng, SY Ko, ... Journal of virology 89 (16), 8334-8345, 2015 | 141 | 2015 |
| Antibody-Dependent Cellular Cytotoxicity against Primary HIV-Infected CD4+ T Cells Is Directly Associated with the Magnitude of Surface IgG Binding A Smalls-Mantey, N Doria-Rose, R Klein, A Patamawenu, SA Migueles, ... Journal of virology 86 (16), 8672-8680, 2012 | 135 | 2012 |
| Sustained delivery of a broadly neutralizing antibody in nonhuman primates confers long-term protection against simian/human immunodeficiency virus infection KO Saunders, A Pegu, IS Georgiev, M Zeng, MG Joyce, ZY Yang, SY Ko, ... Journal of virology 89 (11), 5895-5903, 2015 | 115 | 2015 |
| A single intranasal immunization with inactivated influenza virus and α-galactosylceramide induces long-term protective immunity without redirecting antigen to the central … HJ Youn, SY Ko, KA Lee, HJ Ko, YS Lee, K Fujihashi, PN Boyaka, SH Kim, ... Vaccine 25 (28), 5189-5198, 2007 | 113 | 2007 |
| Bispecific antibodies targeting different epitopes on the HIV-1 envelope exhibit broad and potent neutralization M Asokan, RS Rudicell, M Louder, K McKee, S O'dell, G Stewart-Jones, ... Journal of virology 89 (24), 12501-12512, 2015 | 110 | 2015 |
| Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B HJ Ko, SY Ko, YJ Kim, EG Lee, SN Cho, CY Kang Infection and immunity 73 (9), 5666-5674, 2005 | 104 | 2005 |
| Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial MR Gaudinski, KV Houser, NA Doria-Rose, GL Chen, RSS Rothwell, ... The Lancet HIV 6 (10), e667-e679, 2019 | 86 | 2019 |
| Optimization of the solubility of HIV-1-neutralizing antibody 10E8 through somatic variation and structure-based design YD Kwon, IS Georgiev, G Ofek, B Zhang, M Asokan, RT Bailer, A Bao, ... Journal of virology 90 (13), 5899-5914, 2016 | 83 | 2016 |
| Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccination WP Kong, L Wu, TC Wallstrom, W Fischer, ZY Yang, SY Ko, NL Letvin, ... Journal of virology 83 (5), 2201-2215, 2009 | 82 | 2009 |
| CD1d-Restricted T Cells License B Cells to Generate Long-Lasting Cytotoxic Antitumor Immunity In vivo Y Chung, BS Kim, YJ Kim, HJ Ko, SY Ko, DH Kim, CY Kang Cancer research 66 (13), 6843-6850, 2006 | 81 | 2006 |
| Enhanced efficacy of DNA vaccination against Her‐2/neu tumor antigen by genetic adjuvants SY Chang, KC Lee, SY Ko, HJ Ko, CY Kang International journal of cancer 111 (1), 86-95, 2004 | 74 | 2004 |